hydroxychloroquine has been researched along with bilirubin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Petersen, CS; Thomsen, K | 1 |
| Apostolov, EO; Bose, C; Fahmi, T; Karaduta, OK; Kaushal, GP; Segal, MS; Shah, SV; Shukla, AM | 1 |
| Abdi, A; Bavand, A; Farahani, E; Mazaherpour, H; Mazaherpour, S; Ramezani, A; Sofian, M | 1 |
3 other study(ies) available for hydroxychloroquine and bilirubin
| Article | Year |
|---|---|
High-dose hydroxychloroquine treatment of porphyria cutanea tarda.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Male; Porphyrias; Recurrence; Skin Diseases; Treatment Outcome | 1992 |
Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease.
Topics: Animals; Aorta; Atherosclerosis; Bilirubin; Blood Glucose; Elasticity; Hydroxychloroquine; Inflammation; Male; Mice, Inbred C57BL; Postmortem Changes; Renal Insufficiency, Chronic; Urea; Vascular Stiffness | 2015 |
Comparing Outcomes of Two Antiviral Therapy Combinations among COVID-19 Patients.
Topics: Aged; Antiviral Agents; Arrhythmias, Cardiac; Atazanavir Sulfate; Bilirubin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Length of Stay; Lopinavir; Male; Middle Aged; Ritonavir; SARS-CoV-2; Treatment Outcome | 2022 |